Eloxx Pharmaceuticals Stock Price

-0.0142 (-7.89%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 73,106
Bid Price 0.15
Ask Price 0.1657
News -
Day High 0.185


52 Week Range


Day Low 0.15
Company Name Stock Ticker Symbol Market Type
Eloxx Pharmaceuticals Inc ELOX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0142 -7.89% 0.1657 19:53:00
Open Price Low Price High Price Close Price Prev Close
0.185 0.15 0.185 0.1657 0.1799
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
191 73,106 $ 0.1705364 $ 12,467 - 0.14 - 1.83
Last Trade Time Type Quantity Stock Price Currency
19:41:35 13 $ 0.15 USD


Draw Mode:

Eloxx Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 14.36M 86.66M 58.92M $ - $ - -0.97 -0.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 200.00k 23.20%

more financials information »

Eloxx Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELOX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.19090.19090.140.164735254,104-0.0252-13.2%
1 Month0.38330.420.140.238475228,269-0.2176-56.77%
3 Months0.2390.480.140.2981326218,780-0.0733-30.67%
6 Months0.46940.6150010.140.3255389234,519-0.3037-64.7%
1 Year1.811.830.140.6707268379,752-1.64-90.85%
3 Years4.398.16140.141.89422,934-4.22-96.23%
5 Years10.3524.600.142.88315,463-10.18-98.4%

Eloxx Pharmaceuticals Description

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis.

Your Recent History
Eloxx Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now